Advancing Charge Variant Analysis with pHGradient Ion-Exchange Chromatography: Optimizing Monoclonal Antibody Characterization Using the High-pH Kit for the Alliance™ iS Bio HPLC System

Significance of the Topic

Charge variant analysis is essential for characterizing monoclonal antibody therapeutics and ensuring product consistency, safety, and efficacy.
Analysis of C-terminal lysine modifications and other charge heterogeneity aids regulatory compliance, batch comparability, and biosimilar development.

Objectives and Study Overview

This study evaluates a pH-gradient ion-exchange chromatography method on the Alliance iS Bio HPLC System equipped with a high-pH kit.
Two independent high-pH kits are assessed for reproducibility using a Waters mAb Charge Variant Standard and infliximab samples.

Methodology and Instrumentation

A linear pH gradient from 5.0 to 10.2 over 22.6 minutes enables separation of charge variants by their isoelectric points.
System parameters include a flow rate of 1.44 mL/min, injection volume of 10 µL, column temperature 30 °C, and sample temperature 8 °C.

Applied Instrumentation

• Alliance iS Bio HPLC System with High-pH kit constructed from corrosion-resistant MP35N, PEEK, and titanium
• BioResolve SCX mAb Column (3 µm, 4.6 × 50 mm)
• BioResolve CX pH Concentrates A (pH 5.0) and B (pH 10.2)
• Detection by tunable UV at 280 nm (10 Hz)
• Empower Chromatography Data System for data acquisition and processing

Main Results and Discussion

The method achieved high resolution of acidic, monomeric, and basic variants with average resolution ≥3.1.
Peak area and retention time RSDs were ≤0.7% and 0.0%, respectively, meeting stringent acceptance criteria.
Infliximab analysis showed major lysine variant areas within 0.4% kit-to-kit variation and minor isoforms within 0.8%.
System stability under extreme pH conditions ensures long-term reliability without instrument degradation.

Benefits and Practical Applications of the Method

• High sensitivity for detecting subtle charge variants in complex mAb samples
• Robust reproducibility enables routine batch comparability and biosimilar evaluation
• Corrosion-resistant system design supports extended operation under high-pH conditions

Future Trends and Potential Applications

Advancements may include integration with mass spectrometry for hybrid intact and peptide-level analysis.
Automation and high-throughput workflows could accelerate biopharmaceutical development and quality control.
Further expansion of pH-gradient kits to broader pH ranges and novel stationary phases may enhance variant resolution.

Conclusion

The Alliance iS Bio HPLC System with high-pH enhancements delivers a robust, sensitive, and reproducible pH-gradient IEX method for mAb charge variant analysis.
Consistent performance across multiple kits and samples underscores its suitability for routine monitoring in therapeutic antibody development.

Reference

• Dick L. W. J., Qui D., Mahon D., Adamo M., Cheng K.-C. Investigation of C-terminal Lysine Variants in Fully Human Monoclonal Antibodies: Test Methods and Causes. Biotechnol. Bioeng. 2008;100(6):1132–1143.